Neutralizing monoclonal antibody cocktail REGN-EB3 for Ebola virus disease (EVD)
2 August 2022
| Toolkit
Overview
Both the REGN-EB3 and mAb114 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about effectivenessWHO Team
Editors
World Health Organization
Number of pages
1
Reference numbers
WHO Reference Number: WHO/EVD/therapeutics/REGN-EB3/Poster_A/2022.1